Your browser doesn't support javascript.
loading
Angucyclinones with IDO and TDO inhibitory activities isolated from the actinomycetes Umezawaea beigongshangensis.
Cao, Peng-Ran; Ren, Xiao; Lin, Jie; Mu, Yun-Long; Shan, Yue-Qi; Zhu, Jing-Tong; Xu, Rong-Yi; Zhang, Xue-Xia; Hu, Wei-Guo; Lu, Xin-Hua.
Affiliation
  • Cao PR; New Drug Research and Development Center, North China Pharmaceutical Group Corporation, National Microbial Medicine Engineering and Research Center, Hebei Industry Microbial Metabolic Engineering & Technology Research Center, Shijiazhuang Microbial Drug Technology Innovation Center, Shijiazhuang
  • Ren X; New Drug Research and Development Center, North China Pharmaceutical Group Corporation, National Microbial Medicine Engineering and Research Center, Hebei Industry Microbial Metabolic Engineering & Technology Research Center, Shijiazhuang Microbial Drug Technology Innovation Center, Shijiazhuang
  • Lin J; New Drug Research and Development Center, North China Pharmaceutical Group Corporation, National Microbial Medicine Engineering and Research Center, Hebei Industry Microbial Metabolic Engineering & Technology Research Center, Shijiazhuang Microbial Drug Technology Innovation Center, Shijiazhuang
  • Mu YL; New Drug Research and Development Center, North China Pharmaceutical Group Corporation, National Microbial Medicine Engineering and Research Center, Hebei Industry Microbial Metabolic Engineering & Technology Research Center, Shijiazhuang Microbial Drug Technology Innovation Center, Shijiazhuang
  • Shan YQ; New Drug Research and Development Center, North China Pharmaceutical Group Corporation, National Microbial Medicine Engineering and Research Center, Hebei Industry Microbial Metabolic Engineering & Technology Research Center, Shijiazhuang Microbial Drug Technology Innovation Center, Shijiazhuang
  • Zhu JT; New Drug Research and Development Center, North China Pharmaceutical Group Corporation, National Microbial Medicine Engineering and Research Center, Hebei Industry Microbial Metabolic Engineering & Technology Research Center, Shijiazhuang Microbial Drug Technology Innovation Center, Shijiazhuang
  • Xu RY; New Drug Research and Development Center, North China Pharmaceutical Group Corporation, National Microbial Medicine Engineering and Research Center, Hebei Industry Microbial Metabolic Engineering & Technology Research Center, Shijiazhuang Microbial Drug Technology Innovation Center, Shijiazhuang
  • Zhang XX; New Drug Research and Development Center, North China Pharmaceutical Group Corporation, National Microbial Medicine Engineering and Research Center, Hebei Industry Microbial Metabolic Engineering & Technology Research Center, Shijiazhuang Microbial Drug Technology Innovation Center, Shijiazhuang
  • Hu WG; New Drug Research and Development Center, North China Pharmaceutical Group Corporation, National Microbial Medicine Engineering and Research Center, Hebei Industry Microbial Metabolic Engineering & Technology Research Center, Shijiazhuang Microbial Drug Technology Innovation Center, Shijiazhuang
  • Lu XH; New Drug Research and Development Center, North China Pharmaceutical Group Corporation, National Microbial Medicine Engineering and Research Center, Hebei Industry Microbial Metabolic Engineering & Technology Research Center, Shijiazhuang Microbial Drug Technology Innovation Center, Shijiazhuang
Fitoterapia ; 172: 105716, 2024 Jan.
Article in En | MEDLINE | ID: mdl-37926399
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Tryptophan Oxygenase / Actinobacteria Language: En Journal: Fitoterapia Year: 2024 Type: Article
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Tryptophan Oxygenase / Actinobacteria Language: En Journal: Fitoterapia Year: 2024 Type: Article